norcantharidin has been researched along with Acute Myelogenous Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, WW; DU, J; Fu, MY; Gao, N; Li, S; Yu, WZ | 1 |
| Dorn, DC; Kou, CA; Moore, MA; Png, KJ | 1 |
| Guo, X; Li, S; Shen, H; Tang, Y; Zhang, J | 1 |
3 other study(ies) available for norcantharidin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[NCTD Retards AML HL60 Cell Proliferation via Targeting Hedgehog/SOX2 axis].
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Hedgehog Proteins; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; SOXB1 Transcription Factors; Zinc Finger Protein GLI1 | 2021 |
The effect of cantharidins on leukemic stem cells.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Apoptosis; Arylamine N-Acetyltransferase; Basic-Leucine Zipper Transcription Factors; Bridged Bicyclo Compounds, Heterocyclic; Cantharidin; Caspases; Cell Cycle; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Enzyme Inhibitors; Female; Fetal Blood; Humans; Leukemia, Myeloid, Acute; Luminescence; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Phosphorylation; Proto-Oncogene Proteins c-myc; Snail Family Transcription Factors; STAT5 Transcription Factor; Stromal Cells; Survival Rate; Transcription Factors; Transplantation, Heterologous; Tumor Suppressor Protein p53 | 2009 |
3A4, a new potential target for B and myeloid lineage leukemias.
Topics: Animals; Antibodies, Monoclonal; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Delivery Systems; Epitopes; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Mice; Mice, Inbred BALB C; Papain; Time Factors | 2011 |